i3 Drug Safety Biographies

Dr. Madison is President of i3 Drug Safety, joining i3 Drug Safety as its founding leader in 2005. Terri received her doctorate in epidemiology from the University of Michigan, and a MPH from the University of Michigan School of Public Health. Prior to her current role, Dr. Madison served as Sr. Vice President of Global Operations at i3 Statprobe, a global data services CRO. With over 20 years of biopharmaceutical industry experience, including 8 years at Parke-Davis Pharmaceutical Research and 11 years at STATPROBE, Terri has substantial experience in data collection, analysis, and reporting across multiple therapeutic areas in all phases of research.

In her current role, Dr. Madison’s responsibilities include business and scientific leadership for safety services provided by the pharmacovigilance and clinical epidemiology teams. Dr. Madison often serves in a consulting capacity to both internal and external clients; her core areas of research interest and expertise includes pregnancy surveillance; risk management; and the design, conduct, and analysis of observational cancer studies, where she has worked with both state and national cancer registries to evaluate both social and biological factors associated with prognosis.